Treatment of isolated Systolic hypertension

被引:4
|
作者
Stokes, Gordon S.
机构
[1] Mona Vale, NSW 2103
关键词
D O I
10.1007/s11906-006-0081-0
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Isolated systolic hypertension (ISH) is the dominant form of hypertension in the elderly. It is associated with increased arterial pulse pressure, to which an early-returning and magnified pulse-wave reflection makes an important contribution. Treatment of ISH with diuretics, calcium channel blockers (CCBs), and angiotensin 11 inhibitors is effective in reducing systolic blood pressure, preventing cardiovascular morbid events, and lowering mortality; these agents may have to be used in combination to achieve the systolic blood pressure goal of < 140 mm Hg. Treatment with beta-blockers appears to be less effective. The relative efficacy of various classes of anti hypertensive drugs for lowering pulse pressure and systolic blood pressure is determined in part by their differing abilities to reduce pulse-wave reflection. In patients with ISH that is refractory to dual or triple therapy, measurement of the reflected wave by applanation tonometry may be useful in determining which additional anti hypertensive agent to use.
引用
收藏
页码:377 / 383
页数:7
相关论文
共 50 条
  • [21] Does the treatment of isolated systolic hypertension prevent dementia?
    CE Clarke
    [J]. Journal of Human Hypertension, 1999, 13 : 357 - 358
  • [22] ISOLATED SYSTOLIC HYPERTENSION - ANOTHER DISINCENTIVE TO TREATMENT IS REMOVED
    MATERSON, BJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (19) : 2128 - 2129
  • [23] ISOLATED SYSTOLIC HYPERTENSION
    NEURATH, O
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1992, 40 (05) : 538 - 539
  • [24] Treatment strategies for isolated systolic hypertension in elderly patients
    Angeli, Fabio
    Verdecchia, Paolo
    Masnaghetti, Sergio
    Vaudo, Gaetano
    Reboldi, Gianpaolo
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (14) : 1713 - 1723
  • [25] Isolated systolic hypertension: Cardiovascular risk and treatment benefits
    Farsang, C
    Sleight, P
    [J]. BLOOD PRESSURE, 2002, 11 (01) : 63 - 64
  • [26] Isolated systolic hypertension: Cardiovascular risk and treatment benefits
    Farsang, C
    Sleight, P
    [J]. JOURNAL OF HYPERTENSION, 2001, 19 (12) : 2279 - 2281
  • [27] ENALAPRIL AND VERAPAMIL IN THE TREATMENT OF ISOLATED SYSTOLIC HYPERTENSION IN THE ELDERLY
    ESPINEL, CH
    BRUNER, DE
    DAVIS, JR
    ESPINEL, CF
    WILLIAMS, JL
    [J]. HYPERTENSION, 1993, 21 (04) : 573 - 573
  • [28] A COMPARISON OF AMLODIPINE WITH ENALAPRIL IN THE TREATMENT OF ISOLATED SYSTOLIC HYPERTENSION
    WEBSTER, J
    FOWLER, G
    JEFFERS, TA
    LYONS, D
    WITTE, K
    CRICHTON, WA
    WICKHAM, EA
    SANGHERA, SS
    CORNISH, R
    PETRIE, JC
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 35 (05) : 499 - 505
  • [29] Losartan treatment of patients with isolated systolic hypertension.
    Farsang, C
    Garcia-Puig, J
    Niegowska, J
    Baiz, AQ
    Vrijens, F
    Bortman, G
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 140A - 140A
  • [30] Does the treatment of isolated systolic hypertension prevent dementia?
    Clarke, CE
    [J]. JOURNAL OF HUMAN HYPERTENSION, 1999, 13 (06) : 357 - 358